Forte Biosciences (FBRX) Assets Average (2017 - 2020)
Historic Assets Average for Forte Biosciences (FBRX) over the last 4 years, with Q3 2020 value amounting to $25.5 million.
- Forte Biosciences' Assets Average fell 6727.78% to $25.5 million in Q3 2020 from the same period last year, while for Sep 2020 it was $25.5 million, marking a year-over-year decrease of 6727.78%. This contributed to the annual value of $55.4 million for FY2019, which is 4325.56% down from last year.
- Latest data reveals that Forte Biosciences reported Assets Average of $25.5 million as of Q3 2020, which was down 6727.78% from $23.5 million recorded in Q2 2020.
- In the past 5 years, Forte Biosciences' Assets Average registered a high of $106.5 million during Q3 2017, and its lowest value of $13.1 million during Q1 2020.
- Its 4-year average for Assets Average is $68.9 million, with a median of $83.0 million in 2018.
- As far as peak fluctuations go, Forte Biosciences' Assets Average surged by 14526.1% in 2018, and later tumbled by 8670.94% in 2020.
- Over the past 4 years, Forte Biosciences' Assets Average (Quarter) stood at $97.1 million in 2017, then fell by 0.42% to $96.7 million in 2018, then crashed by 59.47% to $39.2 million in 2019, then tumbled by 34.9% to $25.5 million in 2020.
- Its Assets Average was $25.5 million in Q3 2020, compared to $23.5 million in Q2 2020 and $13.1 million in Q1 2020.